Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Dominik
Contact Dominik, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis
Background With over 570,000 newly diagnosed cases per year, esophageal cancer (EC) is the ninth most common cancer in the world and accounts for 5.3% of cancer case mortality.1 The two main histological subtypes, esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) have a distinct pathogenesis and show strong regional differences.2 While in western countries the incidence of EAC has risen over the past two decades, numbers of ESCC have declined.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Dominik
Contact Dominik, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack